Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.

Arends TJ, Falke J, Lammers RJ, Somford DM, Hendriks JC, de Weijert MC, Arentsen HC, van der Heijden AG, Oosterwijk E, Alfred Witjes J.

World J Urol. 2014 Dec 10. [Epub ahead of print]

PMID:
25491674
[PubMed - as supplied by publisher]
2.

Recent advances in ureteral tissue engineering.

de Jonge PK, Simaioforidis V, Geutjes PJ, Oosterwijk E, Feitz WF.

Curr Urol Rep. 2015 Jan;16(1):465. doi: 10.1007/s11934-014-0465-7.

PMID:
25404179
[PubMed - in process]
Free PMC Article
3.

Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.

van Bracht E, Versteegden LR, Stolle S, Verdurmen WP, Woestenenk R, Raavé R, Hafmans T, Oosterwijk E, Brock R, van Kuppevelt TH, Daamen WF.

PLoS One. 2014 Nov 4;9(11):e110813. doi: 10.1371/journal.pone.0110813. eCollection 2014.

PMID:
25369131
[PubMed - in process]
Free PMC Article
4.

Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer.

Buffen K, Oosting M, Quintin J, Ng A, Kleinnijenhuis J, Kumar V, van de Vosse E, Wijmenga C, van Crevel R, Oosterwijk E, Grotenhuis AJ, Vermeulen SH, Kiemeney LA, van de Veerdonk FL, Chamilos G, Xavier RJ, van der Meer JW, Netea MG, Joosten LA.

PLoS Pathog. 2014 Oct 30;10(10):e1004485. doi: 10.1371/journal.ppat.1004485. eCollection 2014 Oct.

PMID:
25356988
[PubMed - in process]
Free PMC Article
5.

Tissue engineering of diseased bladder using a collagen scaffold in a bladder exstrophy model.

Roelofs LA, Kortmann BB, Oosterwijk E, Eggink AJ, Tiemessen DM, Crevels AJ, Wijnen RM, Daamen WF, van Kuppevelt TH, Geutjes PJ, Feitz WF.

BJU Int. 2014 Sep;114(3):447-57.

PMID:
25302355
[PubMed - indexed for MEDLINE]
6.

Identification of potential bladder progenitor cells in the trigone.

Sun W, Wilhelmina Aalders T, Oosterwijk E.

Dev Biol. 2014 Sep 1;393(1):84-92. doi: 10.1016/j.ydbio.2014.06.018. Epub 2014 Jun 30.

PMID:
24992712
[PubMed - indexed for MEDLINE]
7.

Tissue engineering in animal models for urinary diversion: a systematic review.

Sloff M, de Vries R, Geutjes P, IntHout J, Ritskes-Hoitinga M, Oosterwijk E, Feitz W.

PLoS One. 2014 Jun 25;9(6):e98734. doi: 10.1371/journal.pone.0098734. eCollection 2014.

PMID:
24964011
[PubMed - in process]
Free PMC Article
8.

Correlation Between In Vivo 18F-FDG PET and Immunohistochemical Markers of Glucose Uptake and Metabolism in Pheochromocytoma and Paraganglioma.

van Berkel A, Rao JU, Kusters B, Demir T, Visser E, Mensenkamp AR, van der Laak JA, Oosterwijk E, Lenders JW, Sweep FC, Wevers RA, Hermus AR, Langenhuijsen JF, Kunst DP, Pacak K, Gotthardt M, Timmers HJ.

J Nucl Med. 2014 Jun 12;55(8):1253-1259. [Epub ahead of print]

PMID:
24925884
[PubMed - as supplied by publisher]
9.

Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model.

Muselaers CH, Oosterwijk E, Bos DL, Oyen WJ, Mulders PF, Boerman OC.

Mol Imaging. 2014;13:1-7.

PMID:
24824962
[PubMed - in process]
10.

Tissue engineering of the bladder--reality or myth? A systematic review.

Sloff M, Simaioforidis V, de Vries R, Oosterwijk E, Feitz W.

J Urol. 2014 Oct;192(4):1035-42. doi: 10.1016/j.juro.2014.03.116. Epub 2014 Apr 21. Review.

PMID:
24769032
[PubMed - indexed for MEDLINE]
11.

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.

Muselaers CH, Stillebroer AB, Rijpkema M, Franssen GM, Oosterwijk E, Mulders PF, Oyen WJ, Boerman OC.

J Nucl Med. 2014 Apr 21;55(6):1035-1040. [Epub ahead of print]

PMID:
24752673
[PubMed - as supplied by publisher]
12.

Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.

Kats-Ugurlu G, Oosterwijk E, Muselaers S, Oosterwijk-Wakka J, Hulsbergen-van de Kaa C, de Weijert M, van Krieken H, Desar I, van Herpen C, Maass C, de Waal R, Mulders P, Leenders W.

Neoplasia. 2014 Mar;16(3):221-8. doi: 10.1016/j.neo.2014.03.007. Epub 2014 Apr 13.

PMID:
24726142
[PubMed - in process]
Free PMC Article
13.

Preclinical imaging in bone tissue engineering.

Ventura M, Boerman OC, de Korte C, Rijpkema M, Heerschap A, Oosterwijk E, Jansen JA, Walboomers XF.

Tissue Eng Part B Rev. 2014 Dec;20(6):578-95. doi: 10.1089/ten.TEB.2013.0635. Epub 2014 May 29.

PMID:
24720381
[PubMed - in process]
14.

In vivo magnetic resonance imaging of type I collagen scaffold in rat: improving visualization of bladder and subcutaneous implants.

Sun Y, Geutjes P, Oosterwijk E, Heerschap A.

Tissue Eng Part C Methods. 2014 Dec;20(12):964-71. doi: 10.1089/ten.TEC.2014.0046. Epub 2014 Apr 24.

PMID:
24625324
[PubMed - in process]
15.

Targeting ion transport in cancer.

Oosterwijk E, Gillies RJ.

Philos Trans R Soc Lond B Biol Sci. 2014 Feb 3;369(1638):20130107. doi: 10.1098/rstb.2013.0107. Print 2014 Mar 19.

PMID:
24493755
[PubMed - indexed for MEDLINE]
16.

Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.

van Bracht E, Stolle S, Hafmans TG, Boerman OC, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Eur J Pharm Biopharm. 2014 May;87(1):80-9. doi: 10.1016/j.ejpb.2014.01.005. Epub 2014 Jan 23.

PMID:
24463217
[PubMed - in process]
17.

Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma.

Muselaers CH, Stillebroer AB, Desar IM, Boers-Sonderen MJ, van Herpen CM, de Weijert MC, Langenhuijsen JF, Oosterwijk E, Leenders WP, Boerman OC, Mulders PF, Oyen WJ.

J Nucl Med. 2014 Feb;55(2):242-7. doi: 10.2967/jnumed.113.131110. Epub 2014 Jan 6.

PMID:
24396030
[PubMed - indexed for MEDLINE]
18.

SPECT vs. PET monitoring of bone defect healing and biomaterial performance in vivo.

Ventura M, Franssen GM, Oosterwijk E, Boerman OC, Jansen JA, Walboomers XF.

J Tissue Eng Regen Med. 2014 Jan 6. doi: 10.1002/term.1862. [Epub ahead of print]

PMID:
24390977
[PubMed - as supplied by publisher]
19.

Is there a need for smooth muscle cell transplantation in urethral reconstruction?

Arenas da Silva LF, Micol L, Tiemessen D, van Kuppevelt TH, Frey P, Oosterwijk E, Geutjes P, Feitz WF.

Tissue Eng Part A. 2014 May;20(9-10):1542-9. doi: 10.1089/ten.TEA.2013.0185. Epub 2014 Feb 6.

PMID:
24329538
[PubMed - indexed for MEDLINE]
20.

A common variant at 8q24.21 is associated with renal cell cancer.

Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Petursdottir V, Hardarson S, Gudjonsson SA, Johannsdottir H, Helgadottir HT, Stacey SN, Magnusson OT, Helgason H, Panadero A, van der Zanden LF, Aben KK, Vermeulen SH, Oosterwijk E, Kong A, Mayordomo JI, Sverrisdottir A, Jonsson E, Gudbjartsson T, Einarsson GV, Kiemeney LA, Thorsteinsdottir U, Rafnar T, Stefansson K.

Nat Commun. 2013;4:2776. doi: 10.1038/ncomms3776.

PMID:
24220699
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk